I understand biostatistics lends to a smaller number in a non inferiority trial however I can't see the FDA allowing a number much less than what competitors have had to use ie 900.. It's also telling WP has been hesitant to announce a number which means they are trying to convince the FDA.
- Forums
- ASX - By Stock
- Clinical trials
I understand biostatistics lends to a smaller number in a non...
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.51 |
Change
0.000(0.00%) |
Mkt cap ! $285.5M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1200 | $13.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.69 | 22 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1200 | 13.600 |
1 | 3 | 13.510 |
1 | 10 | 13.350 |
1 | 60 | 13.150 |
1 | 50 | 13.120 |
Price($) | Vol. | No. |
---|---|---|
13.690 | 22 | 1 |
13.700 | 614 | 1 |
14.000 | 1122 | 2 |
14.250 | 328 | 1 |
15.000 | 1000 | 1 |
Last trade - 09.57am 09/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
Day chart unavailable